Ans) The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
- Manufacturers must also prove they are able to make the drug product according to federal quality standards. FDA does not develop or test products before approving them. Instead, FDA experts review the results of laboratory, animal, and human clinical testing done by manufacturers.
do you feel the US food and drug administration should have regulatory responisbility in healthcare ?...
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. The FDA wants to set up a hypothesis test to show that the new drug is...
In the US Food and Drug Administration (USFDA), how many Centers are there in the Office of Medical Products and Tobacco? Which Centers focus on medical devices, biologics, and drugs
Do you feel it is necessary for all healthcare leaders to have a HIT background? Why or Why not
Do you feel that regulatory protocols promote the safe management of health information in telehealth? Why or why not?
Discuss the impact of healthcare policy, finance, and regulatory environments related to safe medication administration.
Why do you feel the government gets involved in healthcare practice?
Why do you feel government gets involved in healthcare practice?
Upon inauguration, the Trump administration implemented a regulatory budget such that in net new regulations should add zero additional cost of compliance to the economy. They also added to this a 2-out, 1-in approach which requires two regulations be eliminated for every new regulation. The early analyses of this program are starting to be published. 1. Why have both both a 2-out, 1-in approach in addition to a low budgetary target for costs? 2. The defenders of this approach believe...
What do you feel are the three biggest data challenges in healthcare today, and why? In addition, what do you see as emerging and future trends in healthcare data and analytics?
Do you feel that companies should have to report on the front cover that the financial statements are reported using fair value (or historical cost)? Why or why not?